← Human Trials & Peer-Reviewed Studies
Supplementing Breakfast with a Vitamin D and Leucine-Enriched Whey Protein Medical Nutrition Drink Enhances Postprandial Muscle Protein Synthesis and Muscle Mass in Healthy Older Men.
Plain-language guide to PMID 28835387 (2017): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 24 men.
Key Facts
- PMID
- 28835387
- Journal
- The Journal of nutrition
- Year
- 2017
- Study type
- Randomized Controlled Trial
- Authors
- Chanet A et al. (16 authors)
- DOI
- 10.3945/jn.117.252510
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.
Who Took Part
According to the abstract, 24 men were involved.
The age groups tagged for this paper are older adults, men only.
How the Study Was Run
In design terms this was a randomized, double-blind and placebo-controlled study.
Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
Blinding on both sides kept the men and researchers unaware of who received Vitamin D, K2, Magnesium and Zinc.
A placebo (an inactive look-alike) gave the Vitamin D, K2, Magnesium and Zinc group a baseline to be compared against.
Mixed muscle protein fractional synthesis rate (FSR) was measured at week 0 in the basal and postprandial state, after study product intake with a standardized breakfast with the use of l-[2H5]-phenylalanine tracer methodology.
What Was Measured
The subject headings attached to it are Beverages, Breakfast, Diet, Energy Intake, Food Analysis, Gene Expression Regulation and Leucine.
The authors tagged it with the keywords muscle mass, muscle protein synthesis, protein intake, sarcopenia and vitamin D.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc in 24 men.
With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.
The publication is from 2017 (The Journal of nutrition), a journal based in United States.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.